Key points are not available for this paper at this time.
Cardiopulmonary exercise testing (CPET) has an established role in the assessment of patients with heart failure. However, data are lacking in patients with transthyretin (ATTR) amyloidosis.
Patel et al. (Wed,) studied this question.